NEW YORK (Reuters) – An old malaria treatment that has been tried with some success against the new coronavirus and was touted by U.S. President Donald Trump at a news briefing earlier on Thursday is in short supply as demand surges amid the fast-spreading outbreak.

To read the rest of this article by Michael Erman, including a quote from Valisure CEO David Light, click here.